Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for detecting red blood cell DNA damage signal and its application in lymphoma prognosis

A technology of lymphoma and signaling, applied in the field of medicine and biology, to achieve the effect of improving detection efficiency, reducing pain, and widely used

Active Publication Date: 2020-06-09
杭州太铭生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the diversity of DLBCL pathogenic factors, age of onset, and disease grading, the chemotherapy regimen needs to be followed up in real time. However, the evaluation of the chemotherapy effect at this stage still needs to be based on the doctor's subjective experience and the pathological results obtained after puncture. This method is repeated for patients. Invasive puncture procedures are also a pain for patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for detecting red blood cell DNA damage signal and its application in lymphoma prognosis
  • A method for detecting red blood cell DNA damage signal and its application in lymphoma prognosis
  • A method for detecting red blood cell DNA damage signal and its application in lymphoma prognosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] In order to make the purpose, technical solutions and advantages of the present invention clearer, the following in conjunction with specific examples, and with reference to the appended Figure 1-10 , to further describe the present invention in detail.

[0029] Before introducing the specific implementation content of the present invention, the nouns involved in this implementation content are briefly explained and introduced:

[0030] Erythrocyte DNA damage signal: Mature erythrocytes have no nucleus. If in the early stage of erythrocyte maturation, chromatids or chromosomes are acentric fragments, or the entire chromosome is lost due to spindle damage, in the late stage of cell division, some DNA nucleic acid fragments remain in the cytoplasm, that is to say, these residual DNA signals will form one or several regular subnuclei in the cytoplasm of mature erythrocytes, and these subnuclei are residual DNA damage signals.

[0031] CD235a: Glycophorin A, is a single t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medical biology. The application of red blood cell DNA damage signals in lymphoma prognosis includes the following steps: S1: prepare blood samples; S2: clean and process the control group and experimental group; S3: stain and process the second experimental group; S4: Resuspend the second control group; S5: Detect the third experimental group and the third control group by flow cytometry; S6: Analyze the results; S7, compare the changes in the proportion of the patient's own DNA damage signal, and simultaneously establish the relationship between healthy people and lymphoma The DNA damage signal database of the disease population can quickly and effectively compare the DNA damage signal of patients with lymphoma disease with the database to evaluate the prognosis of patients with lymphoma disease. Using trace blood samples and reagents, this method can quickly determine the DNA damage signal in early damaged red blood cells in lymphoma patients, which has the advantages of strong specificity and high sensitivity.

Description

technical field [0001] The invention belongs to the field of medicine and biology, and specifically relates to a method for detecting red blood cell DNA damage signals and its application in lymphoma prognosis. Background technique [0002] Lymphoma is a type of hematopoietic malignant tumor caused by lymphocyte (a type of white blood cell) lesions. Clinical symptoms generally include lymph node enlargement but no pain, fever, night sweats, weight loss, itching and fatigue and other systemic symptoms. Lymphoma has many subtypes according to different classification methods. The main classification method is to divide it into non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL) according to the tumor cells. The pathological features of HL include lymphocytes, eosinophils, plasma cells and specific Reed-Steinberg cells in the tumor tissue. The incidence of NHL is much higher than that of HL, accounting for about 90%, which is the sum of a group of independent diseases wit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68G01N33/58G01N33/80G01N15/14
CPCG01N33/6842G01N33/58G01N33/80G01N15/14G01N2015/1486G01N15/149
Inventor 葛建萍李丹丹
Owner 杭州太铭生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com